N P Konovalova Selected Research

Leukemia P388

7/2017	The Effectiveness of Cyclic Hydroxamic Acid CHA-5 against Drug-Resistant P388 Leukemia Strains.
2/2003	Nitric oxide donor increases the efficiency of cytostatic therapy and retards the development of drug resistance.
1/2003	Ultralow doses of various drugs in chemotherapy of experimental tumors.
1/2003	[Nitric oxide donor increases the effectiveness of cytostatic therapy and inhibits the development of drug resistance].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

N P Konovalova Research Topics

Disease

9	Neoplasms (Cancer) 07/2017 - 01/2000
4	Leukemia P388 07/2017 - 01/2003
4	Leukemia 01/2013 - 01/2000
4	Experimental Melanoma 01/2006 - 11/2002
3	Neoplasm Metastasis (Metastasis) 01/2006 - 01/2000
1	Necrosis 04/2009
1	Leukemia L1210 11/2002
1	Colorectal Neoplasms (Colorectal Cancer) 01/2000

Drug/Important Bio-Agent (IBA)

5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2017 - 01/2003
3	Hydroxamic Acids (Hydroxamic Acid)IBA 07/2017 - 01/2013
3	Cisplatin (Platino)FDA LinkGeneric 07/2017 - 11/2002
3	Cytostatic AgentsIBA 02/2003 - 11/2002
3	Mitomycin (Mitomycin-C)FDA LinkGeneric 01/2003 - 01/2000
2	Pharmaceutical PreparationsIBA 07/2017 - 11/2002
2	Daunorubicin (Cerubidine)FDA LinkGeneric 07/2017 - 01/2000
2	Proteins (Proteins, Gene)FDA Link 04/2009 - 11/2002
2	Nitric Oxide DonorsIBA 04/2009 - 02/2003
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2003 - 01/2000
2	DNA (Deoxyribonucleic Acid)IBA 11/2002 - 12/2001
2	AK 2123IBA 12/2001 - 01/2000
1	Vincristine (Oncovin)FDA LinkGeneric 07/2017
1	OxidesIBA 01/2013
1	EnzymesIBA 01/2013
1	Mechlorethamine (Nitrogen Mustard)FDA Link 01/2013
1	Adenosine Triphosphatases (ATPase)IBA 08/2008
1	IonsIBA 01/2006
1	Immunologic Factors (Immunomodulators)IBA 01/2003
1	AntioxidantsIBA 01/2003
1	Biological ProductsIBA 01/2003
1	lonidamineIBA 01/2003
1	Ecdysterone (20 Hydroxyecdysone)IBA 11/2002
1	Antineoplastic Agents (Antineoplastics)IBA 11/2002
1	Carrier Proteins (Binding Protein)IBA 12/2001
1	TriazolesIBA 01/2000
1	ruboxylIBA 01/2000
1	nitroxylIBA 01/2000
1	Fluorouracil (Carac)FDA LinkGeneric 01/2000
1	Etoposide (VP 16)FDA LinkGeneric 01/2000

Therapy/Procedure

5	Therapeutics 07/2017 - 11/2002
2	Transplantation 07/2017 - 02/2003
1	Drug Therapy (Chemotherapy) 01/2003
1	Intravenous Infusions 01/2000